| Date | Title | Description |
| 08.02.2024 | Neurona Therapeutics Raises $120M to Advance Groundbreaking ... | San Francisco, CA, February 8, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company... |
| 13.11.2023 | ViaNautis is developing a nanovesicle platform designed to d... | Cambridge UK, 13 November 2023 – ViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking nano... |
| 26.10.2023 | Neurona's groundbreaking work is making waves in the media! ... | https://www.nbcnews.com/now/video/doctors-test-experimental-treatment-to-combat-seizures-in-epilepsy... |
| 17.10.2023 | SpliceBio Enters Collaboration with Spark Therapeutics to De... | BARCELONA, 17 October, 2023 – SpliceBio, a genetic medicines company harnessing Protein Splicing to ... |
| 21.06.2023 | SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Deve... | - |
| 15.06.2023 | Walden Biosciences Announces First Subject Dosed in First-in... | - |
| 18.05.2023 | Neurona Therapeutics Presents Updated Data from the NRTX-100... | - |
| 16.03.2023 | Switch Therapeutics Launches with $52 Million to Advance Fir... | - |
| 16.03.2023 | ExeVir Bio and VIB Announce Data on a New Therapy for Preven... | - |
| 14.11.2022 | Code Biotherapeutics Names Alex S. Tracy, PhD, as Chief Tech... | Greater Philadelphia, Pa., November 14, 2022 – Code Biotherapeutics, Inc. (Code Bio), a biotechnolog... |
| 11.10.2022 | Walden Biosciences Appoints Peter Guest Linde, M.D. as Chief... | CAMBRIDGE, Mass., Oct. 11, 2022 – Walden Biosciences, Inc. (Walden), a private, venture-backed biote... |
| 28.09.2022 | Code Biotherapeutics Names David Anderson, PhD, as Chief Sci... | Greater Philadelphia, Pa., September 28, 2022 — Code Biotherapeutics, Inc., (Code Bio), a biotechnol... |
| 29.06.2022 | Neurona Therapeutics Announces Initial Subject Dosed in Firs... | June 29, 2022 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerativ... |
| 07.06.2022 | Code Biotherapeutics Raises Upsized and Oversubscribed $75 M... | Greater Philadelphia, Pa., June 7, 2022 — Code Biotherapeutics, Inc., (Code Bio), a biotechnology co... |
| 01.03.2022 | AbbVie Acquires Syndesi Therapeutics, Strengthening Neurosci... | AbbVie, 01 March 2022: AbbVie (NYSE: ABBV) today announced it has completed the acquisition of Synde... |
| 16.02.2022 | SpliceBio Raises EUR 50M in Oversubscribed Series A financin... | SpliceBio, 16 February 2022: SpliceBio, a biotechnology company exploiting protein splicing to devel... |
| 15.12.2021 | EsoBiotec | 15 December 2021: EsoBiotec is a biotechnology company developing an in vivo engineering platform to... |
| 29.10.2021 | Walden: targeting podocytes as linchpin for kidney function | Walden, 29 October 2021: targeting podocytes as linchpin for kidney function. |
| 21.10.2021 | Syndesi Therapeutics announces commencement of dosing in cli... | Syndesi, 21 October 2021: Syndesi Therapeutics announces commencement of dosing in clinical trial of... |
| 01.09.2021 | ExeVir Announces First Patient Enrolled in Phase 1b/2 Clinic... | Belgium, 1 September 2021: ExeVir, which is developing single domain antibody therapies providing br... |
| 18.08.2021 | ExeVir announces first subjects dosed in Phase I clinical st... | Belgium, 18 August 2021: ExeVir, which is developing single domain antibody therapies providing broa... |
| 22.04.2021 | ExeVir’s CRO hunt for Phase II/III COVID-19 subQ antibody tr... | 13 Jul 2021. ExeVir Bio will open its doors to CRO pitches mid-year for a Phase II/III trial investi... |
| 19.04.2021 | Neurona Therapeutics Presents Preclinical Data from Lead Cel... | 18 Jun 2021. Neurona is a cell therapy company focused on the development of breakthrough treatments... |
| 16.03.2021 | StrideBio Announces Closing of $81.5M Series B Financing | Research Triangle Park, N.C., Mar. 16, 2021 – StrideBio, Inc., a leading developer of novel engineer... |
| 16.03.2021 | ExeVir Announces Close of US$50 million / EUR42 million Seri... | Belgium, March 16th, 2021: ExeVir, which is developing single domain antibody therapies providing br... |
| 18.02.2021 | UCB Ventures and AXA Venture Partners: seeking innovation in... | 18 Feb 2021. In this interview, UCB Ventures Partner, Delphine Hajaji, connects with François Robine... |
| 27.01.2021 | Syndesi Therapeutics announces positive results from two add... | 27 January 2021. Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel mo... |
| 14.12.2020 | Locanabio Announces $100 Million Series B Financing to Advan... | 14 Dec 2020. Locanabio, Inc., an RNA-targeting gene therapy company focused on developing life-chang... |
| 06.10.2020 | Walden seeking to develop breakthrough medicines to reverse ... | 06 Oct 2020. Walden Biosciences, Inc. (Walden), a biotechnology company focused on transforming the ... |
| 28.07.2020 | ExeVir Bio to Accelerate Development of New Treatment Confer... | 28 Jul 2020. ExeVir Bio announces today a first closing of a EUR23 million Series A financing led by... |
| 19.12.2019 | Syndesi Therapeutics announces the expansion of its manageme... | 19 Dec 2019. Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel modula... |
| 10.12.2019 | Locana Expands Leadership Team with Appointment of former Ca... | 10 Dec 2019. Locana, Inc., a leading RNA-targeting gene therapy company, today announced the appoint... |
| 14.11.2019 | Sarepta and StrideBio Announce Multi-target Collaboration to... | 14 Nov 2019. Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases,... |
| 04.09.2019 | Locana appoints Kathie Bishop, Ph.D., as Chief Scientific Of... | 04 Sep 2019. Locana, a leading RNA-targeting gene therapy company, today announced the appointment o... |
| 31.07.2019 | Ally secured seed finance from ARCH Venture Partners, Alta P... | 31 July 2019. Ally secured seed finance from ARCH Venture Partners, Alta Partners and UCB Ventures t... |
| 28.03.2019 | StrideBio and Takeda Sign Collaboration and License Agreemen... | 28 March 2019. Multi-target deal will utilize StrideBio's platform to identify unique AAV capsids fo... |
| 20.03.2019 | Syndesi Therapeutics awarded non-dilutive funding of up to €... | 20 March 2019. Developing novel SV2A modulators for cognitive impairment, today announced it has bee... |
| 06.03.2019 | UCB Ventures Appoints Alicia Irurzun-Lafitte as Partner | 06 March 2019. UCB Ventures, the corporate venture arm of UCB Pharma, today announced that Alicia Ir... |
| 19.02.2019 | CRISPR Therapeutics and StrideBio Expand Exclusive Developme... | 19 February 2019. CRISPR Therapeutics, a biopharmaceutical company focused on creating transformativ... |
| 03.01.2019 | StrideBio Appoints Sapan Shah, Ph.D. as Chief Executive Offi... | 03 January 2019. StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based ge... |
| 22.06.2018 | Read the interview with Erica Whittaker in BioCentury | 22 June 2018. Description: UCB Ventures' recent investment in Durham, N.C.-based gene therapy play S... |
| 13.06.2018 | UCB Ventures makes its first direct investment | 13 June 2018. UCB Ventures announces its first direct investment in the oversubscribed $15.7 million... |
| 01.02.2018 | UCB and investor syndicate led by Novo Seeds launch Syndesi ... | 01 February 2018. We have recently announced the creation of Syndesi Therapeutic to further develop ... |
| - | Locana Raises $55 Million Series A Financing to Advance Port... | 22 May 2019. Locana, Inc., a leading RNA-targeting gene therapy company, announced today the close o... |
| - | Rinri Therapeutics secures £1.4 million seed funding to adva... | 20 May 2019. Rinri Therapeutics, a biotechnology company developing a novel cell- based therapy to r... |
| - | Syndesi Therapeutics announces initiation of Phase I study o... | 08 May 2019. Syndesi Therapeutics SA, a biotechnology company developing novel modulators of the syn... |